GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Healthcare Group Co Ltd (HKSE:02453) » Definitions » ROCE %

Concord Healthcare Group Co (HKSE:02453) ROCE % : -7.07% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Concord Healthcare Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Concord Healthcare Group Co's annualized ROCE % for the quarter that ended in Jun. 2024 was -7.07%.


Concord Healthcare Group Co ROCE % Historical Data

The historical data trend for Concord Healthcare Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Healthcare Group Co ROCE % Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROCE %
-16.46 -29.09 -13.01 -7.55

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROCE % Get a 7-Day Free Trial -32.77 -7.91 -7.28 -7.62 -7.07

Concord Healthcare Group Co ROCE % Calculation

Concord Healthcare Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-355.025/( ( (6043.13 - 1045.376) + (5727.459 - 1317.475) )/ 2 )
=-355.025/( (4997.754+4409.984)/ 2 )
=-355.025/4703.869
=-7.55 %

Concord Healthcare Group Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=-324.742/( ( (5727.459 - 1317.475) + (6157.566 - 1384.628) )/ 2 )
=-324.742/( ( 4409.984 + 4772.938 )/ 2 )
=-324.742/4591.461
=-7.07 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Healthcare Group Co  (HKSE:02453) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Concord Healthcare Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Concord Healthcare Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Healthcare Group Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is primarily generated from its hospital business and its medical equipment, software, and related services segment.
Executives
China International Capital Corporation Limited
Zhong Jin Zi Ben Yun Ying You Xian Gong Si
Zhong Jin Jia Tai Er Qi Tian Jin Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Ascendium Group Limited
Concord Medical Services Holdings Limited
Morgancreek Investment Holdings Limited
Yang Jianyu
Zhang Bi
Beijing Concord Medical Technology Co., Ltd.
Concord Hospital Management Group Limited
Shanghai Medstar Financial Leasing Company Limited
Tianjin Concord Medical Technology Co., Ltd.

Concord Healthcare Group Co Headlines

No Headlines